Cargando…
The efficacy and safety of patent Foramen Ovale Closure for Refractory Epilepsy (PFOC-RE): a prospectively randomized control trial of an innovative surgical therapy for refractory epilepsy patients with PFO of high-grade right-to-left shunt
BACKGROUND: A significant proportion of patients with epilepsy have an unknown etiology and lack effective targeted therapeutic drugs. Patent Foramen Ovale (PFO) induces hypoxia and microembolism, leading to cerebral neurological dysfunction and increased epilepsy risk. This study aims to assess the...
Autores principales: | Shuming, Ji, Hua, Li, Yusha, Tang, Lei, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373383/ https://www.ncbi.nlm.nih.gov/pubmed/37501155 http://dx.doi.org/10.1186/s12883-023-03317-0 |
Ejemplares similares
-
Editorial: Patent Foramen Ovale (PFO) Closure for Prevention of Stroke
por: Kokkinidis, Damianos G., et al.
Publicado: (2021) -
Association of patent foramen ovale with epilepsy: A hospital‐based case–control study
por: Tang, Yusha, et al.
Publicado: (2023) -
Multisite and multitimepoint proteomics reveal that patent foramen ovale closure improves migraine and epilepsy by reducing right‐to‐left shunt‐induced hypoxia
por: Dong, Bosi, et al.
Publicado: (2023) -
Multidisciplinary management of patent foramen ovale (PFO) and cryptogenic stroke/TIA
por: Mirzada, Naqibullah, et al.
Publicado: (2013) -
First direct evidence of a Patent Foramen Ovale (PFO): a large thrombus straddling the foramen ovale
por: Shang, Xiaoke, et al.
Publicado: (2016)